Aleris Pharmaceuticals Limited

Aleris Pharmaceuticals Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials and compliance.
CIN U24304WB2021PLC245141 Incorporated 13 May 2021 ROC Kolkata HQ Kolkata, West Bengal, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹75.07 Cr
Latest filing
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹20 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Last financials
Mar 2025
Balance sheet date

About Aleris Pharmaceuticals Limited

Data last updated: 16 February 2026

Aleris Pharmaceuticals Limited is a public limited company based in Kolkata, West Bengal, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 13 May 2021, the company has been in operation for over 5 years.

Registered with ROC Kolkata under CIN U24304WB2021PLC245141.

Capital: an authorised share capital of ₹50 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Anand Kumar Parmanandka and Rubi Mukhopadhyay.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 55 B.R.B. Basu Road, Kolkata, West Bengal, India – 700001.

As per the financials filed for FY 2025, the company reported a revenue of ₹75.07 Cr.

As per MCA filings, the company has open charges of ₹20 Cr on record.

Company Details of Aleris Pharmaceuticals Limited
CIN U24304WB2021PLC245141
Registration Number 245141
Incorporation Date 13 May 2021
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    55 B.R.B. Basu Road, Kolkata, West Bengal, India – 700001
  • Industry
    Pharma, Drug Formulation & Development
Company report
Aleris Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Aleris Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Aleris Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Aleris Pharmaceuticals Limited

Aleris Pharmaceuticals Limited is engaged in principal business activities including manufacturing and trade, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, retail trading. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
G Trade G2 Retail Trading Locked
Premium access

Business activity turnover details for Aleris Pharmaceuticals Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Aleris Pharmaceuticals Limited

Aleris Pharmaceuticals Limited is audited by H.P. JHUNJHUNWALA & CO. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
H.P. JHUNJHUNWALA & CO. Locked Locked Locked
Premium access

Complete auditor history for Aleris Pharmaceuticals Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Aleris Pharmaceuticals Limited

Aleris Pharmaceuticals Limited is governed by 3 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Anand Kumar Parmanandka Director 13 May 2021 5 Years 2 Months Current
Rubi Mukhopadhyay Director 13 May 2021 5 Years 2 Months Current
Biswajit Pan Director 13 May 2021 5 Years 2 Months Current

Financials of Aleris Pharmaceuticals Limited FY 2025 filings available

Aleris Pharmaceuticals Limited reported revenue of ₹75.07 Cr for FY 2025.

Revenue · FY 2025
₹75.07 Cr
Premium access

Ten-year financial statements for Aleris Pharmaceuticals Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Aleris Pharmaceuticals Limited

Premium access

Shareholding and ownership data for Aleris Pharmaceuticals Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Aleris Pharmaceuticals Limited

Open charges
₹20 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Others₹20.00 Cr
Latest charge details
DateLenderAmountStatus
11 Nov 2025 Others ₹20 Cr Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Aleris Pharmaceuticals Limited

Aleris Pharmaceuticals Limited has a workforce of 0 employees as of Apr 09, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history for Aleris Pharmaceuticals Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Aleris Pharmaceuticals Limited

Premium access

GST registrations and filing compliance for Aleris Pharmaceuticals Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Aleris Pharmaceuticals Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Aleris Pharmaceuticals Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Aleris Pharmaceuticals Limited

Premium access

MSME payment history for Aleris Pharmaceuticals Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Aleris Pharmaceuticals Limited

Premium access

Corporate group structure for Aleris Pharmaceuticals Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Aleris Pharmaceuticals Limited

Premium access

MCA filings and documents for Aleris Pharmaceuticals Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Aleris Pharmaceuticals Limited

Charges
11 Nov 2025
A charge with Others amounted to Rs. 2,000.00 Lakh with Charge ID 101189765 was registered on 11 Nov 2025.
Activity
30 Sep 2025
Aleris Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Aleris Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Directors
13 May 2021
Anand Kumar Parmanandka was appointed as a Director on 13 May 2021 & has been associated with this company since 5 years 2 months.
Directors
13 May 2021
Rubi Mukhopadhyay was appointed as a Director on 13 May 2021 & has been associated with this company since 5 years 2 months.
Directors
13 May 2021
Biswajit Pan was appointed as a Director on 13 May 2021 & has been associated with this company since 5 years 2 months.

Frequently Asked Questions about Aleris Pharmaceuticals Limited

Aleris Pharmaceuticals Limited is an active public limited company in the pharma sector based in Kolkata, West Bengal, India. It was incorporated on 13 May 2021 (5+ years old) and is registered under CIN U24304WB2021PLC245141.

Aleris Pharmaceuticals Limited reported revenue of ₹75.07 Cr for FY 2025.

The current directors of Aleris Pharmaceuticals Limited are:

The primary industry of Aleris Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Aleris Pharmaceuticals Limited can be reached at the registered office: 55 B.R.B. Basu Road, Kolkata, West Bengal, India – 700001.

The authorised capital is ₹50 Lakh, and the paid-up capital is ₹5 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available